Price $13.04 |
Market Cap
792.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
13.7
|
P/B
5.31
|
P/S
6.39
|
Dividend %
-
|
|
P/CF
19.2
|
P/FCF
-
|
Op. Cash Flow
73K
|
FCF
-
|
|
Op. Margin
64.30%
|
Net Margin
50.10%
|
ROE
49.50%
|
ROI
39.70%
|
|
ROA
41.80%
|
EPS Growth
15.60%
|
Current Ratio
6.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Lannett Company, Inc. (LCI) | $0.58 | - | - | 22.4M | Strong Buy |
| Endo International PLC (ENDP) | $0.37 | - | - | 124.1M | Strong Buy |
| Psychemedics Corp. (PMD) | $6.29 | - | 4.50% | 35.3M | Strong Buy |
| Cyclo Therapeutics Inc (CYTH) | $2.10 | - | - | 19.4M | Strong Buy |
| Lineage Cell Therapeutics Inc (LCTX) | $1.37 | - | - | 212.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
